|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0033308,
umls-concept:C0034656,
umls-concept:C0036667,
umls-concept:C0040808,
umls-concept:C0043210,
umls-concept:C0232970,
umls-concept:C0312418,
umls-concept:C0442027,
umls-concept:C0443199,
umls-concept:C0483249,
umls-concept:C1280500,
umls-concept:C1831768
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2003-9-15
|
|
pubmed:abstractText |
Activated protein C (APC) resistance not related to the factor V Leiden mutation is a risk factor for venous thrombosis. Oral estrogen replacement therapy (ERT) has been reported to induce APC resistance. Little is known about the effect of transdermal estrogen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
pubmed-author:AbgrallJean-FrançoisJF,
pubmed-author:AiachMartineM,
pubmed-author:Alhenc-GelasMartineM,
pubmed-author:BlouchMarie-ThérèseMT,
pubmed-author:ColletMichelM,
pubmed-author:KerlanVéroniqueV,
pubmed-author:LacutKarineK,
pubmed-author:MottierDominiqueD,
pubmed-author:OgerEmmanuelE,
pubmed-author:RoudautNathalieN,
pubmed-author:SARAH Investigators,
pubmed-author:ScarabinPierre-YvesPY
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1671-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.
|
|
pubmed:affiliation |
Département de Médecine Interne, Hôpital de la Cavale Blanche, Brest, France. emmanual.oger@southernhealth.org.au
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
